Clinical Trial Update: A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluated bevacizumab in combination with capecitabine in locally advanced rectal cancer to assess safety and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-15